Skip to main content
. Author manuscript; available in PMC: 2018 Nov 15.
Published in final edited form as: Biol Psychiatry. 2017 Jul 8;84(10):722–733. doi: 10.1016/j.biopsych.2017.06.032

Figure 7. Effects of GAT211 and paclitaxel on ovarian tumor cell viability.

Figure 7

(A) Paclitaxel reduces HeyA8 tumor cell viability in MTT assay. (B) GAT211 (20 μM) alone did not alter tumor cell viability and did not impede ability of paclitaxel (20 nM) to reduce tumor cell viability in HeyA8 cells. Values are means ± SEM of 8-16 replicates per determination. Effects of GAT211shown are representative of three independent assays. *P<0.05 vs. basal, #P<0.05 vs. 0.01nM paclitaxel, one-way ANOVA followed by Bonferroni post hoc test.